The 20 Best Fibrolamellar Carcinoma Doctors Near Me in Dallas, TX

Robert Goldstein, MD, FACS is a Clinical Professor at Texas A&M College of Medicine at Texas A&M Health Science Center, Dallas. He is Medical Director of the Liver and Pancreas Disease Center at the Annette C. and Harold C. Simmons Transplant Institute. He is also Chief of Hebatobilliary Surgery and Director of the General Surgery Residency Program at Baylor University Medical Center, part of Baylor Scott & White Health. Dr. Goldstein's clinical interests include liver cancer, bile duct cancer and bile duct injuries. He provides immediate evaluation and medical management of patients with newly diagnosed benign and cancerous liver lesions. He and a team of transplant and oncologic surgery specialists work together to offer aggressive advanced treatments. With 30 years of experience in a high-volume transplant center, Dr. Goldstein is one of the most practiced hepatobilliary surgeons in the nation. Dr. Goldstein received his medical degree from the University of Tennessee Health Science Center in Memphis. He completed his residency at West Virginia University School of Medicine. He went on to start a transplant fellowship at the University of Pittsburgh and completed the transplant fellowship at Baylor University Medical Center in Dallas where he has dedicated his entire medical career to the care and treatment of liver cancer patients and liver transplant patients. Read more about Dr. Goldstein's publications on PubMed.gov and the Baylor Health Sciences Library. Read more about Dr. Goldstein's publications. Dr. Goldstein has been named one of D Magazine’s Best Docs at least 15 times earning him a place on D Magazine’s Hall of Fame list. Dr. Goldstein has been named one of Texas Monthly's Texas Super Doctors for the past 15 years earning him a place on Texas Monthly's Legacy list. Dr. Goldstein is rated as a Distinguished provider by MediFind in the treatment of Fibrolamellar Carcinoma. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Fibrolamellar Carcinoma, Progressive Familial Intrahepatic Cholestasis Type 2, Progressive Familial Intrahepatic Cholestasis Type 1, Liver Transplant, and Splenectomy. Dr. Goldstein is board certified in Transplant Surgery- American Board Of Surgery/General Surgery, - American Board Of Surgery/General Surgery, General Surgery- American Board Of Surgery/General Surgery, Transplant Surgery- American Board Of Surgery, and General Surgery- American Board Of Surgery.

Ashwini Mehta is a Hepatologist and a Transplant Surgeon practicing medicine in Dallas, Texas. Dr. Mehta is rated as a Distinguished provider by MediFind in the treatment of Fibrolamellar Carcinoma. She is also highly rated in 4 other conditions, according to our data. Her clinical expertise encompasses Fibrolamellar Carcinoma, Ascites, Liver Failure, Hepatitis, and Liver Transplant. Dr. Mehta is board certified in Transplant Hepatology- American Osteopathic Board Of Internal Medicine and Internal Medicine- American Osteopathic Board Of Internal Medicine.

Parvez Mantry is a Hepatologist and a Gastroenterologist practicing medicine in Dallas, Texas. Dr. Mantry is rated as a Distinguished provider by MediFind in the treatment of Fibrolamellar Carcinoma. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Nonalcoholic Steatohepatitis (NASH), Hepatitis, Liver Failure, Liver Transplant, and Endoscopy. Dr. Mantry is board certified in Gastroenterology- American Board Of Internal Med.

"Dr. Beecherl is a Clinical Associate Professor at Texas A&M College of Medicine at Texas A&M Health Science Center, Dallas. Dr. Beecherl is a board-certified general surgeon with a focus on hepato-biliary and pancreatic surgery, islet autotransplantation and gastrointestinal oncologic surgery. He has practiced in Dallas since finishing his fellowship training in 1999. Prior to moving to Baylor University Medical Center, part of Baylor Scott & White Health, in Dallas, he practiced at Presbyterian Hospital of Dallas serving in several leadership positions including the Executive Committee of the Medical Board and seven years as Chairman of the Department of General Surgery. He has been named one of the ""Best Doctors in Dallas"" by D Magazine perennially since 2001. He has also been recognized as a ""Texas Super Doctor"" by Texas Monthly Magazine for the last several consecutive years. Dr. Beecherl received his Bachelor of Science degree in Chemical Engineering from the University of Texas, at Austin in 1986, his Masters of Science in Anatomy from Tulane University Graduate School in 1991, and his Doctorate of Medicine from Tulane University Medical Center in 1991. Dr. Beecherl started his post-graduate training in Dallas as a surgical intern at Parkland Memorial Hospital in 1991. He then trained for six years at the University of Texas Southwestern Medical Center which included two years of laboratory research and four years of residency which he finished in 1998 as the Administrative Surgical Chief Resident of Parkland. His last year of training was a fellowship in Hepato-Biliary and Pancreatic Surgery at the Toronto General Hospital in Toronto, Ontario. After completing his fellowship, Dr. Beecherl returned to Dallas and was a founding partner of Southwest General Surgery Associates. In 2016 he moved to Baylor's Simmons Transplant Institute and serves as the Director of Islet Autotransplantation. Dr. Beecherl is a Fellow of the American College of Surgeons, a Diplomat of the American Board of Surgery, and a member of Dallas County Medical Society, the Texas Medical Society, the Parkland Surgical Society, and the American Hepato-Biliary and Pancreatic Association. Dr. Beecherl is a native of Dallas who stays active outside the hospital raising four children with his wife, Susan, and by serving on several civic, church, and foundation boards. See Dr. Beecherl's Publications here. Read more about Dr. Beecherl's publications on PubMed.gov and the Baylor Health Sciences Library . Dr. Beecherl has been named one of Texas Monthly's Texas Super Doctors for the past 20 years earning him a place on Texas Monthly's 20 Years Legacy list.". Dr. Beecherl is rated as an Advanced provider by MediFind in the treatment of Fibrolamellar Carcinoma. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Hereditary Pancreatitis, Childhood Pancreatitis, Acute Pancreatitis, Islet Cell Transplantation, and Pancreatectomy. Dr. Beecherl is board certified in Transplant Surgery- American Board Of Surgery/General Surgery, Transplant Surgery- American Board Of Surgery, and General Surgery- American Board Of Surgery.

Dr. Testa is a Clinical Professor at Texas A&M College of Medicine at Texas A&M Health Science Center, Dallas. He is Chief of Abdominal Transplant at Baylor University Medical Center, part of Baylor Scott & White Health and Chairman of the Annette C. and Harold C. Simmons Transplant Institute. He specializes in living donor liver transplantation and is the principal investigator of the Uterine Transplant Clinical Trial that resulted in the first U.S. birth of a baby following uterine transplant. Dr. Testa was honored in 2018 as one of TIME Magazine's Top 100 for leading the medical team that performed the first successful uterus transplants in the nation. Dr. Testa is a graduate of t he University of Padova Medical School in Italy. After graduating cum laude, he completed a residency in general surgery at the same university. He went on to complete a general surgery residency at the University of Chicago and then a fellowship in abdominal organ transplant at Baylor University Medical Center in Dallas. Later at the University of Essen in Germany, he was instrumental in starting the first adult living donor liver transplant program in Europe. Dr. Testa returned to the U.S. in 2001, where he served as Director of Liver Transplant at the University of Illinois. In 2005, he moved to the University of Chicago where he rose to the rank of Professor of Surgery and served as Director of Liver Transplant and Hepatobilliary Surgery. Read more about Dr. Testa's publications on PubMed.gov and the Baylor Health Sciences Library. Dr. Testa returned to Baylor University Medical Center in 2011 to lead the Living Donor Liver Program. He became Chief of Abdominal Transplant for the Annette C. and Harold C. Simmons Transplant Institute in 2017. Dr. Testa is author or co-author of more than 160 publications and several book chapters. He is a recognized authority in Uterus Transplantation and Living Donor Liver Transplantation. His other interests include complex liver surgery of benign and malignant diseases. Read more about Dr. Testa Dr. Testa has been named one of Texas Monthly's Texas Super Doctors for over 10 years earning him a place on Texas Monthly's Hall of Fame list. Dr. Testa is rated as an Advanced provider by MediFind in the treatment of Fibrolamellar Carcinoma. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Liver Failure, Hepatitis, Fibrolamellar Carcinoma, Liver Transplant, and Hysterectomy. Dr. Testa is board certified in Transplant Surgery- American Board Of Surgery/General Surgery and Transplant Surgery- American Board Of Surgery.

Dr. Suzie Lee is a Clinical Assistant Professor at Texas A&M College of Medicine at Texas A&M Health Science Center, Dallas. She is a multi-organ transplant surgeon, performing liver, kidney and pancreas transplants. Her professional interests include biliary disease and complex gastrointestinal issues of the pancreas and liver. As an accomplished hepatopancreatic biliary surgeon, she provides patients with innovative treatment and surgical options for liver, pancreas and bile duct cancer. After earning her medical degree from University of Pittsburgh School of Medicine, she completed her residency in general surgery at Vanderbilt University in Nashville, TN. She went on to complete a fellowship in abdominal transplant surgery at Washington University School of Medicine in St. Louis. Before pursuing medicine, Dr. Lee served in the Peace Corps in Mali, West Africa and worked as a book publicist in New York. Dr. Lee is active in the International Hepato-Pancreato Biliary Association and the American Society of Transplant Surgeons. When she is not operating, Dr. Lee enjoys exploring Texas and experiencing new adventures with her husband and children. Dr. Lee is rated as an Advanced provider by MediFind in the treatment of Fibrolamellar Carcinoma. She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Fibrolamellar Carcinoma, Chronic Antibody-Mediated Rejection, Visceromegaly, Kidney Transplant, and Simultaneous Pancreas Kidney Transplant. Dr. Lee is board certified in Transplant Surgery- American Board Of Surgery/General Surgery, Transplant Surgery- American Board Of Surgery, and General Surgery- American Board Of Surgery.

Jason Moss is a Radiologist and an Interventional Radiologist practicing medicine in Dallas, Texas. Dr. Moss is rated as an Advanced provider by MediFind in the treatment of Fibrolamellar Carcinoma. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Ascites, Bile Duct Obstruction, Jaundice, Liver Embolization, and Bone Marrow Aspiration. Dr. Moss is board certified in Interventional Radiology/Diagnostic Radiology- American Board Of Radiology/Interventional Radiology And Diagnostic Radiology, Interventional Radiology And Diagnostic Radiology- American Board Of Radiology/Interventional Radiology And Diagnostic Radiology, and Interventional Radiology And Diagnostic Radiology- American Board Of Radiology.

Chet Rees is a Radiologist and an Interventional Radiologist practicing medicine in Dallas, Texas. He has been practicing medicine for over 44 years. Dr. Rees is rated as an Advanced provider by MediFind in the treatment of Fibrolamellar Carcinoma. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Ascites, Fibrolamellar Carcinoma, Angiosarcoma of the Liver, Bone Marrow Aspiration, and Liver Embolization. Dr. Rees is board certified in Interventional Radiology And Diagnostic Radiology- American Board Of Radiology/Interventional Radiology And Diagnostic Radiology, Diagnostic Radiology- American Board Of Radiology/Diagnostic Radiology, Diagnostic Radiology- American Board Of Radiology, and Interventional Radiology And Diagnostic Radiology- American Board Of Radiology.

Marco Cura is a Radiologist practicing medicine in Dallas, Texas. Dr. Cura is rated as an Advanced provider by MediFind in the treatment of Fibrolamellar Carcinoma. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Ascites, Pleural Effusion, Fibrolamellar Carcinoma, Liver Embolization, and Gastrostomy. Dr. Cura is board certified in Interventional Radiology And Diagnostic Radiology- American Board Of Radiology/Interventional Radiology And Diagnostic Radiology and Interventional Radiology And Diagnostic Radiology- American Board Of Radiology.

Dr. Orr specializes in Medical Oncology and Hematology with a board certification in Internal Medicine and Medical Oncology.Dr. Orr attended medical school at Vanderbilt University Medical School in Nashville, TN. He then completed an Internal Medicine residency at Vanderbilt University Hospital in Nashville, TN and a Medical Oncology fellowship at the Johns Hopkins Oncology Center in Baltimore, MD.He is a Diplomate of the American Board of Internal Medicine. Dr. Orr is rated as a Distinguished provider by MediFind in the treatment of Fibrolamellar Carcinoma. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Fibrolamellar Carcinoma, Gastric Lymphoma, Myeloproliferative Neoplasms (MPN), and Liver Cancer. Dr. Orr is board certified in Medical Oncology- American Board Of Internal Med/Medical Oncology, Internal Medicine- American Board Of Internal Med, Internal Medicine- American Board Of Internal Medicine, and Medical Oncology- American Board Of Internal Medicine.

Scott Celinski is a Surgical Oncologist and a General Surgeon practicing medicine in Dallas, Texas. Dr. Celinski is rated as an Experienced provider by MediFind in the treatment of Fibrolamellar Carcinoma. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Familial Pancreatic Cancer, Cholangiocarcinoma (Bile Duct Cancer), Pancreatectomy, and Pancreaticoduodenectomy. Dr. Celinski is board certified in General Surgery- American Board Of Surgery/General Surgery, Surgical Critical Care- American Board Of Surgery/Surgical Critical Care, General Surgery- American Board Of Surgery, and Surgical Critical Care- American Board Of Surgery.

Dr. Paulson is board certified in Medical Oncology and Internal Medicine. He serves as the co-director of the Gastrointestinal Research Program for The US Oncology Network, as well as the medical director for the Neuroendocrine Research and Treatment Center at Baylor Charles A. Sammons Cancer Center.Dr. Paulson is active in clinical research focused on neuroendocrine tumors, as well as cancers of the pancreas, liver, esophagus, stomach and colon. Dr. Paulson is rated as an Experienced provider by MediFind in the treatment of Fibrolamellar Carcinoma. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Neuroendocrine Tumor, Pancreatic Cancer, Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET), Gastrostomy, and Endoscopy. Dr. Paulson is board certified in Medical Oncology- American Board Of Internal Med/Medical Oncology and Medical Oncology- American Board Of Internal Medicine.

Dr. Nadler specializes in medical oncology. He serves as a Medical Director of US Oncology Health Informatics and Internet Technology. He remains active in USON research committees in lung cancer, head and neck cancer, and sarcoma within the developmental committees. Dr. Nadler received a BA with highest honors from Wesleyan University double majoring in molecular biology and philosophy. He received his joint MD/MPP from Harvard Medical School and a Master in Public Policy from Harvard University's Kennedy School of Government. Dr. Nadler then completed his internship and residency in Boston, MA, at Brigham and Women's Hospital in Boston and his oncology fellowship at Dana Farber Cancer Institute/MGH. Dr. Nadler is rated as an Experienced provider by MediFind in the treatment of Fibrolamellar Carcinoma. He is also highly rated in 38 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Adenoid Cystic Carcinoma, Bone Tumor, and Fibrosarcoma. Dr. Nadler is board certified in Medical Oncology- American Board Of Internal Med/Medical Oncology and Medical Oncology- American Board Of Internal Medicine.

Dr. O'Shaughnessy is a Medical Oncologist that focuses on breast cancer prevention and treatment. She founded The School of Breast Oncology, a program providing a curriculum-based program focused exclusively on breast cancer clinical management. Dr. O'Shaughnessy attended medical school at Yale University School of Medicine in New Haven, CT. She then completed her Internal Medicine residency at Massachusetts General Hospital in Boston, MA and a Medical Oncology fellowship at National Cancer Institute in Bethesda, MD. She is co-chair of Breast Cancer Research, chair of Breast Cancer Prevention Research at Baylor Charles A. Sammons Cancer Center and a member of the Scientific Advisory Board for US Oncology Research Network. Dr. O'shaughnessy is rated as an Experienced provider by MediFind in the treatment of Fibrolamellar Carcinoma. She is also highly rated in 14 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Triple-Negative Breast Cancer, PIK3CA-Related Overgrowth Spectrum, Inflammatory Breast Cancer, and Tissue Biopsy. Dr. O'shaughnessy is board certified in Medical Oncology- American Board Of Internal Med/Medical Oncology, Internal Medicine- American Board Of Internal Med, Internal Medicine- American Board Of Internal Medicine, and Medical Oncology- American Board Of Internal Medicine.

Dr. Maisel specializes in hematologic malignancies, benign hematology, multiple myeloma, myelodysplasia, lymphoma and bleeding disorders.He attended medical school at the University of Pittsburgh School of Medicine in Pennsylvania. He then completed an Internal Medicine residency at Ohio State University Hospital in Columbus, OH and a Hematology/Oncology fellowship at Case Western Reserve University in Cleveland, OH.Dr. Maisel enjoys hiking, fitness, travel and reading about history. Dr. Maisel is rated as an Experienced provider by MediFind in the treatment of Fibrolamellar Carcinoma. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Aplastic Anemia, Smoldering Multiple Myeloma, and Bone Marrow Aspiration. Dr. Maisel is board certified in Hematology- American Board Of Internal Med/Hematology, Internal Medicine- American Board Of Internal Med, Internal Medicine- American Board Of Internal Medicine, and Hematology- American Board Of Internal Medicine.

Mark Walberg is an Oncologist practicing medicine in Dallas, Texas. Dr. Walberg is rated as a Distinguished provider by MediFind in the treatment of Fibrolamellar Carcinoma. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Fibrolamellar Carcinoma, Liver Cancer, Lung Cancer, Pleuropulmonary Blastoma, and Liver Embolization.

Dr. Yeshika Sharma is a board-certified transplant hepatologist with an interest in treating primary biliary cholangitis, primary sclerosing cholangitis, viral hepatitis, autoimmune hepatitis, hepatocellular carcinoma, alcohol-related liver disease, metabolic associated steatohepatitis, hereditary hemochromatosis and alpha-1 antitrypsin disease. Dr. Sharma is a member of the American Association for the Study of Liver Diseases and is certified in internal medicine, gastroenterology and transplant hepatology. Dr. Sharma is rated as an Experienced provider by MediFind in the treatment of Fibrolamellar Carcinoma. She is also highly rated in 14 other conditions, according to our data. Her clinical expertise encompasses Liver Failure, Alcoholic Cirrhosis, Spontaneous Bacterial Peritonitis, Hepatitis, and Liver Transplant. Dr. Sharma is board certified in Transplant Hepatology- American Board Of Internal Med/Transplant Hepatology, Internal Medicine- American Board Of Internal Med, Gastroenterology- American Board Of Internal Med/Gastroenterology, Internal Medicine- American Board Of Internal Medicine, Transplant Hepatology- American Board Of Internal Medicine, and Gastroenterology- American Board Of Internal Medicine.

Dr. Bahirwani is fellowship-trained and board certified in transplant hepatology, gastroenterology and internal medicine. Her professional interests include management of patients with end stage liver disease, liver transplantation and hepatocellular carcinoma. Dr. Bahirwani is a committed educator and currently serves as Associate Program Director for the Department of Internal Medicine at Baylor University Medical Center, part of Baylor Scott & white Health. She attended medical school at Northwestern University Feinberg School of Medicine in Chicago, Illinois. Dr. Bahirwani's internship, residency and fellowships in gastroenterology and in transplant hepatology, took place at the Hospital of the University of Pennsylvania in Philadelphia, where she was appointed Chief Fellow and Associate Fellowship Program Director of Transplant Hepatology. She joined the faculty and staff of Liver Consultants of Texas at Baylor University Medical Center in 2016. Dr. Bahirwani enjoys traveling with her family. In her free time, she volunteers providing medical care and other resources to the underserved populations of her community. Dr. Bahirwani, MD was recognized by D Magazine as a Best Doctor for 2023, 2024 and 2025. Read more about Dr. Bahirwani’s publications on PubMed.gov and the Baylor Health Sciences Library . Dr. Bahirwani is rated as an Experienced provider by MediFind in the treatment of Fibrolamellar Carcinoma. She is also highly rated in 13 other conditions, according to our data. Her clinical expertise encompasses Visceromegaly, Ascites, Cirrhosis, Liver Transplant, and Endoscopy. Dr. Bahirwani is board certified in Transplant Hepatology- American Board Of Internal Med/Transplant Hepatology, Gastroenterology- American Board Of Internal Med/Gastroenterology, Gastroenterology- American Board Of Internal Medicine, Transplant Hepatology- American Board Of Internal Medicine, and Internal Medicine- American Board Of Internal Medicine.

Dr. Mahgoub is fellowship-trained in transplant hepatology and gastroenterology. He attended medical school at the University of Iowa Carver College of Medicine and completed his internal medicine residency training at the University of Texas Southwestern in Dallas. Before joining the hepatology team at Baylor University Medical Center, part of Baylor Scott & White Health, Dr. Mahgoub worked in transplant hepatology at the University of Minnesota where he was involved in direct patient care, liver disease research and clinical trials. His professional interests include chronic liver disease management, liver transplantation and fatty liver disease. Read more about Dr. Mahgoub's publications on PubMed.gov and the Baylor Health Sciences Library . Dr. Mahgoub has been named a Texas Super Doctor for 2023, 2024, and 2025 by Texas Monthly. Dr. Mahgoub is rated as an Experienced provider by MediFind in the treatment of Fibrolamellar Carcinoma. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Liver Failure, Hepatitis, Congenital Hepatic Fibrosis, and Hepatitis C. Dr. Mahgoub is board certified in Transplant Hepatology- American Board Of Internal Med/Transplant Hepatology, Gastroenterology- American Board Of Internal Med/Gastroenterology, Gastroenterology- American Board Of Internal Medicine, and Transplant Hepatology- American Board Of Internal Medicine.

"Dr. Rahimi is board certified in transplant hepatatology, gastroenterology and internal medicine. His clinical interests include chronic liver disease, liver cancer, liver failure, metabolic and autoimmune diseases of the liver, viral hepatitis, complications of cirrhosis and liver transplantation. Dr. Rahimi has authored several research articles on improving the outcomes of patients with advanced liver disease. Dr. Rahimi holds a Master of Science in Applied Physiology from Finch University of Health Sciences in North Chicago and medical degree from Chicago Medical School. While completing his internship and residency in Internal Medicine at the University of Virginia in Charlottesville, VA, he concurrently obtained a Master of Science in Clinical Research in the Department of Public Health. Upon relocating to Dallas, Dr. Rahimi completed two fellowships, the first in Gastroenterology at the University of Texas Southwestern Medical Center followed by a fellowship in Transplant Hepatology at Baylor University Medical Center, part of Baylor Scott & White Health, in Dallas. Read more about Dr. Rahimi’s publications on PubMed.gov and the Baylor Health Sciences Library . Read Dr. Rahimi's article, ""5 things you need to know about fatty liver disease (and how to reverse it)"" . Dr. Rahimi is involved in a study around the use of statins in patients with advanced liver failure and cirrhosis. Read more here . Dr. Rahimi was recognized by D Magazine as a Best Doctor for 2024 and 2025. Read Dr. Rahimi's article, ""Can fatty liver be reversed? 5 common questions, answered.""". Dr. Rahimi is rated as an Experienced provider by MediFind in the treatment of Fibrolamellar Carcinoma. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Liver Failure, Esophageal Varices, Ascites, Liver Transplant, and Hepato-Pancreato-Biliary Surgery. Dr. Rahimi is board certified in Gastroenterology- American Board Of Internal Med/Gastroenterology, Transplant Hepatology- American Board Of Internal Med/Transplant Hepatology, Gastroenterology- American Board Of Internal Medicine, and Transplant Hepatology- American Board Of Internal Medicine.